US President Donald Trump has signed a wide-ranging executive order. It targets drug costs by directing pharmaceutical companies to lower their prices. The goal is to align with rates paid in other developed countries. This executive order marks a clear initiative where Trump targets drug costs. It fulfills a key campaign promise. The move was met with scepticism from analysts…